BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/27/2022 1:17:37 PM | Browse: 480 | Download: 912
 |
Received |
|
2022-01-31 13:00 |
|
Peer-Review Started |
|
2022-01-31 13:01 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-03-25 02:37 |
|
Revised |
|
2022-04-11 14:21 |
|
Second Decision |
|
2022-07-06 08:08 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-07-11 19:25 |
|
Articles in Press |
|
2022-07-11 19:25 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-07-13 03:46 |
|
Publish the Manuscript Online |
|
2022-07-27 13:17 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Dario Spanu, Andrea Pretta, Eleonora Lai, Mara Persano, Clelia Donisi, Stefano Mariani, Marco Dubois, Marco Migliari, Giorgio Saba, Pina Ziranu, Valeria Pusceddu, Marco Puzzoni, Giorgio Astara and Mario Scartozzi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mario Scartozzi, MD, Chairman, Full Professor, Medical Oncology Unit, University Hospital and University of Cagliari, SS 554 km 4500 Bivio per Sestu, Monserrato 09042, Cagliari, Italy. marioscartozzi@gmail.com |
| Key Words |
Hepatocellular carcinoma; Gut microbiota; Gut–liver axis; Fecal microbiota transplantation; Carcinogenesis; Immune checkpoint inhibitors |
| Core Tip |
The gut-liver axis plays an important role in the pathogenesis of liver diseases, including hepatocellular carcinoma (HCC). Growing evidence has supported the role of the gut microbiota in the development of HCC and as a prognostic and predictive factor. Thus, manipulation of the gut microbiota might represent a novel way to treat or prevent HCC. |
| Publish Date |
2022-07-27 13:17 |
| Citation |
Spanu D, Pretta A, Lai E, Persano M, Donisi C, Mariani S, Dubois M, Migliari M, Saba G, Ziranu P, Pusceddu V, Puzzoni M, Astara G, Scartozzi M. Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment. World J Hepatol 2022; 14(7): 1319-1332 |
| URL |
https://www.wjgnet.com/1948-5182/full/v14/i7/1319.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v14.i7.1319 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
